Valuation Update With 7 Day Price Move • Jun 15
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥67.29, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 198% over the past three years. Declared Dividend • May 30
Dividend of CN¥1.20 announced Shareholders will receive a dividend of CN¥1.20. Ex-date: 4th June 2026 Payment date: 4th June 2026 Dividend yield will be 2.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (43% earnings payout ratio) but not covered by cash flows (108% cash payout ratio). The dividend has increased by an average of 30% per year over the past 6 years. However, payments have been volatile during that time. EPS is expected to grow by 38% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Apr 28
First quarter 2026 earnings released: EPS: CN¥0.83 (vs CN¥0.66 in 1Q 2025) First quarter 2026 results: EPS: CN¥0.83 (up from CN¥0.66 in 1Q 2025). Revenue: CN¥1.40b (up 15% from 1Q 2025). Net income: CN¥505.8m (up 26% from 1Q 2025). Profit margin: 36% (up from 33% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Announcement • Apr 28
Zhejiang Sanmei Chemical Industry Co.,Ltd., Annual General Meeting, May 20, 2026 Zhejiang Sanmei Chemical Industry Co.,Ltd., Annual General Meeting, May 20, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Wuyi, Zhejiang China Announcement • Mar 30
Zhejiang Sanmei Chemical Industry Co.,Ltd. to Report Q1, 2026 Results on Apr 28, 2026 Zhejiang Sanmei Chemical Industry Co.,Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 Valuation Update With 7 Day Price Move • Jan 23
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥68.00, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 167% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥96.51 per share. Price Target Changed • Jan 13
Price target increased by 7.0% to CN¥77.60 Up from CN¥72.50, the current price target is provided by 1 analyst. New target price is 37% above last closing price of CN¥56.80. Stock is up 35% over the past year. The company is forecast to post earnings per share of CN¥3.52 for next year compared to CN¥1.28 last year. Announcement • Dec 26
Zhejiang Sanmei Chemical Industry Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026 Zhejiang Sanmei Chemical Industry Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026 Reported Earnings • Oct 30
Third quarter 2025 earnings: EPS exceeds analyst expectations Third quarter 2025 results: EPS: CN¥0.97 (up from CN¥0.29 in 3Q 2024). Revenue: CN¥1.60b (up 60% from 3Q 2024). Net income: CN¥596.3m (up 237% from 3Q 2024). Profit margin: 37% (up from 18% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.4%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth. Announcement • Sep 30
Zhejiang Sanmei Chemical Industry Co.,Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Zhejiang Sanmei Chemical Industry Co.,Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Reported Earnings • Aug 24
Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Second quarter 2025 results: EPS: CN¥0.97 (up from CN¥0.38 in 2Q 2024). Revenue: CN¥1.62b (up 49% from 2Q 2024). Net income: CN¥594.1m (up 159% from 2Q 2024). Profit margin: 37% (up from 21% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 5.4%. Earnings per share (EPS) exceeded analyst estimates by 9.9%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 24% per year. Announcement • Jul 02
Stallion India Fluorochemicals Limited Fully Settle its Legal Long Dispute with Zhejiang Sanmei Chemical Industry Co., Ltd Stallion India Fluorochemicals Limited (SIFL) has fully settled its legal long dispute with Zhejiang Sanmei Chemical Industry Co. Ltd. The Company has made a full and final payment of USD 1,251,290, thereby settling all outstanding claims and closing the matter definitively. The Company has received a No Due Letter from ZSCICL and has been informed that the matter has also been formally closed with the China Export & Credit Insurance Corporation (SINOSURE). This payment was already provided for in the financial statements for the half year ended September 30, 2024, and reflected under trade payables in the audited financial results for the quarter ended March 31, 2025. Announcement • Jun 30
Zhejiang Sanmei Chemical Industry Co.,Ltd. to Report First Half, 2025 Results on Aug 23, 2025 Zhejiang Sanmei Chemical Industry Co.,Ltd. announced that they will report first half, 2025 results on Aug 23, 2025 Declared Dividend • Jun 07
Dividend increased to CN¥0.45 Dividend of CN¥0.45 is 96% higher than last year. Ex-date: 11th June 2025 Payment date: 11th June 2025 Dividend yield will be 0.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (27% earnings payout ratio) but not covered by cash flows (dividend approximately 5x free cash flows). The dividend has increased by an average of 7.0% per year over the past 5 years. However, payments have been volatile during that time. EPS is expected to grow by 87% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • May 02
First quarter 2025 earnings released: EPS: CN¥0.66 (vs CN¥0.25 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.66 (up from CN¥0.25 in 1Q 2024). Revenue: CN¥1.21b (up 26% from 1Q 2024). Net income: CN¥400.5m (up 160% from 1Q 2024). Profit margin: 33% (up from 16% in 1Q 2024). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. Major Estimate Revision • Apr 30
Consensus EPS estimates increase by 42% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from CN¥5.34b to CN¥5.52b. EPS estimate increased from CN¥2.02 to CN¥2.87 per share. Net income forecast to grow 150% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥40.78 to CN¥43.99. Share price rose 5.0% to CN¥44.10 over the past week. Announcement • Apr 29
Zhejiang Sanmei Chemical Industry Co.,Ltd., Annual General Meeting, May 20, 2025 Zhejiang Sanmei Chemical Industry Co.,Ltd., Annual General Meeting, May 20, 2025, at 14:30 China Standard Time. Announcement • Mar 28
Zhejiang Sanmei Chemical Industry Co.,Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Zhejiang Sanmei Chemical Industry Co.,Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Announcement • Dec 27
Zhejiang Sanmei Chemical Industry Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025 Zhejiang Sanmei Chemical Industry Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025 Valuation Update With 7 Day Price Move • Dec 23
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥37.75, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 72% over the past three years. Major Estimate Revision • Nov 04
Consensus revenue estimates fall by 12% The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥4.74b to CN¥4.17b. EPS estimate fell from CN¥1.30 to CN¥1.25 per share. Net income forecast to grow 59% next year vs 55% growth forecast for Chemicals industry in China. Consensus price target down from CN¥54.73 to CN¥40.04. Share price rose 2.4% to CN¥33.18 over the past week. Reported Earnings • Oct 30
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: EPS: CN¥0.29 (up from CN¥0.18 in 3Q 2023). Revenue: CN¥999.1m (up 14% from 3Q 2023). Net income: CN¥177.2m (up 64% from 3Q 2023). Profit margin: 18% (up from 12% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 39%. Earnings per share (EPS) also missed analyst estimates by 55%. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Announcement • Sep 30
Zhejiang Sanmei Chemical Industry Co.,Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Zhejiang Sanmei Chemical Industry Co.,Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥32.75, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 23% over the past three years. Major Estimate Revision • Aug 28
Consensus EPS estimates fall by 12% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥4.89b to CN¥4.74b. EPS estimate also fell from CN¥1.47 per share to CN¥1.30 per share. Net income forecast to grow 105% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥59.07 to CN¥54.73. Share price fell 7.9% to CN¥27.16 over the past week. Price Target Changed • Aug 28
Price target decreased by 7.3% to CN¥54.73 Down from CN¥59.07, the current price target is provided by 1 analyst. New target price is 102% above last closing price of CN¥27.16. Stock is down 11% over the past year. The company is forecast to post earnings per share of CN¥1.30 for next year compared to CN¥0.46 last year. Announcement • Jun 28
Zhejiang Sanmei Chemical Industry Co.,Ltd. to Report First Half, 2024 Results on Aug 27, 2024 Zhejiang Sanmei Chemical Industry Co.,Ltd. announced that they will report first half, 2024 results on Aug 27, 2024 New Risk • May 21
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 25% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. This is currently the only risk that has been identified for the company. Major Estimate Revision • May 06
Consensus EPS estimates increase by 65%, revenue downgraded The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast fell from CN¥4.99b to CN¥4.91b. EPS estimate rose from CN¥1.48 to CN¥2.45. Net income forecast to grow 434% next year vs 56% growth forecast for Chemicals industry in China. Consensus price target down from CN¥61.94 to CN¥59.07. Share price was steady at CN¥42.48 over the past week. New Risk • May 02
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 25% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. This is currently the only risk that has been identified for the company. Announcement • May 01
Zhejiang Sanmei Chemical Industry Co.,Ltd., Annual General Meeting, May 21, 2024 Zhejiang Sanmei Chemical Industry Co.,Ltd., Annual General Meeting, May 21, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Wuyi County, Zhejiang China Reported Earnings • Apr 30
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: CN¥0.46 (down from CN¥0.80 in FY 2022). Revenue: CN¥3.33b (down 30% from FY 2022). Net income: CN¥279.6m (down 42% from FY 2022). Profit margin: 8.4% (down from 10% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.9%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Mar 30
Zhejiang Sanmei Chemical Industry Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Zhejiang Sanmei Chemical Industry Co.,Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Announcement • Jan 02
Zhejiang Sanmei Chemical Industry Co., Ltd. (SHSE:603379) announces an Equity Buyback for CNY 160 million worth of its shares. Zhejiang Sanmei Chemical Industry Co., Ltd. (SHSE:603379) announces a share repurchase program. Under the program, the company will repurchase CNY 160 million worth of its shares. Announcement • Dec 29
Zhejiang Sanmei Chemical Industry Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024 Zhejiang Sanmei Chemical Industry Co., Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024 New Risk • Nov 02
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (23% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.8% average weekly change). Profit margins are more than 30% lower than last year (7.3% net profit margin). Reported Earnings • Nov 02
Third quarter 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.12 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.18 (up from CN¥0.12 in 3Q 2022). Revenue: CN¥872.7m (down 21% from 3Q 2022). Net income: CN¥108.3m (up 53% from 3Q 2022). Profit margin: 12% (up from 6.4% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 14% per year. Reported Earnings • Aug 26
Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.25 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.25 in 2Q 2022). Revenue: CN¥958.7m (down 31% from 2Q 2022). Net income: CN¥109.7m (down 27% from 2Q 2022). Profit margin: 11% (in line with 2Q 2022). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 09
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥31.60, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 46% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.53 per share. Valuation Update With 7 Day Price Move • Jul 13
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥27.22, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 25% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥20.49 per share. Major Estimate Revision • Apr 28
Consensus revenue estimates fall by 28% The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥5.64b to CN¥4.07b. EPS estimate fell from CN¥1.82 to CN¥1.20 per share. Net income forecast to grow 51% next year vs 46% growth forecast for Chemicals industry in China. Consensus price target down from CN¥40.00 to CN¥39.00. Share price fell 16% to CN¥28.70 over the past week. Valuation Update With 7 Day Price Move • Apr 27
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥30.86, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 52% over the past three years. Reported Earnings • Apr 22
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: EPS: CN¥0.80 (down from CN¥0.88 in FY 2021). Revenue: CN¥4.77b (up 18% from FY 2021). Net income: CN¥485.6m (down 9.4% from FY 2021). Profit margin: 10% (down from 13% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 12%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 16% per year. Buying Opportunity • Jan 16
Now 21% undervalued Over the last 90 days, the stock is up 1.6%. The fair value is estimated to be CN¥33.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 20% in 2 years. Earnings is forecast to grow by 96% in the next 2 years. Buying Opportunity • Dec 12
Now 22% undervalued Over the last 90 days, the stock is up 5.2%. The fair value is estimated to be CN¥36.85, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 20% in 2 years. Earnings is forecast to grow by 96% in the next 2 years. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 2 highly experienced directors. 2 independent directors (4 non-independent directors). Independent Director Xiao Liang was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Nov 04
Investor sentiment improved over the past week After last week's 22% share price gain to CN¥28.70, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 18% over the past three years. Reported Earnings • Oct 30
Third quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.17 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.17 in 3Q 2021). Revenue: CN¥1.20b (up 24% from 3Q 2021). Net income: CN¥117.7m (up 16% from 3Q 2021). Profit margin: 9.8% (in line with 3Q 2021). Revenue is forecast to grow 5.6% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has fallen by 3% per year. Reported Earnings • Aug 29
Second quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.13 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.13 in 2Q 2021). Revenue: CN¥1.39b (up 50% from 2Q 2021). Net income: CN¥151.0m (up 94% from 2Q 2021). Profit margin: 11% (up from 8.4% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jul 19
Investor sentiment improved over the past week After last week's 22% share price gain to CN¥27.87, the stock trades at a trailing P/E ratio of 25.3x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 2.6% over the past three years. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. General Manager & Chairman of the Board Qixiang Hu was the last director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 31
Third quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.07 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥970.7m (up 36% from 3Q 2020). Net income: CN¥101.5m (up 151% from 3Q 2020). Profit margin: 11% (up from 5.7% in 3Q 2020). Reported Earnings • Aug 27
Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.12 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥927.4m (up 29% from 2Q 2020). Net income: CN¥78.0m (up 7.1% from 2Q 2020). Profit margin: 8.4% (down from 10% in 2Q 2020). Valuation Update With 7 Day Price Move • Jul 28
Investor sentiment deteriorated over the past week After last week's 19% share price decline to CN¥20.22, the stock trades at a trailing P/E ratio of 67.5x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 8.9% over the past year. Valuation Update With 7 Day Price Move • Jul 05
Investor sentiment improved over the past week After last week's 23% share price gain to CN¥20.68, the stock trades at a trailing P/E ratio of 69x. Average trailing P/E is 29x in the Chemicals industry in China. Total loss to shareholders of 9.7% over the past year. Reported Earnings • Apr 25
First quarter 2021 earnings released: EPS CN¥0.10 (vs CN¥0.16 in 1Q 2020) The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2021 results: Revenue: CN¥840.7m (up 20% from 1Q 2020). Net income: CN¥63.5m (down 36% from 1Q 2020). Profit margin: 7.6% (down from 14% in 1Q 2020). Valuation Update With 7 Day Price Move • Feb 23
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥18.17, the stock is trading at a trailing P/E ratio of 45.1x, up from the previous P/E ratio of 38.4x. This compares to an average P/E of 37x in the Chemicals industry in China. Total return to shareholders over the past year is a loss of 32%. Is New 90 Day High Low • Feb 01
New 90-day low: CN¥16.42 The company is down 12% from its price of CN¥18.56 on 03 November 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period. Is New 90 Day High Low • Jan 07
New 90-day low: CN¥17.94 The company is down 9.0% from its price of CN¥19.68 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Dec 16
New 90-day high: CN¥21.16 The company is up 3.0% from its price of CN¥20.63 on 17 September 2020. The Chinese market is also up 3.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 6.0% over the same period. Reported Earnings • Oct 30
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥245.5m, down 71% from the prior year. Total revenue was CN¥2.94b over the last 12 months, down 30% from the prior year. Announcement • Oct 28
Zhejiang Sanmei Chemical Industry Co.,Ltd. to Report Q3, 2020 Results on Oct 30, 2020 Zhejiang Sanmei Chemical Industry Co.,Ltd. announced that they will report Q3, 2020 results on Oct 30, 2020 Is New 90 Day High Low • Oct 27
New 90-day low: CN¥19.28 The company is down 14% from its price of CN¥22.35 on 29 July 2020. The Chinese market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period. Is New 90 Day High Low • Sep 24
New 90-day low: CN¥20.00 The company is down 6.0% from its price of CN¥21.34 on 24 June 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. Announcement • Jul 09
Zhejiang SANMEI Chemical Industry Co., Ltd. to Report First Half, 2020 Results on Aug 22, 2020 Zhejiang SANMEI Chemical Industry Co., Ltd. announced that they will report first half, 2020 results on Aug 22, 2020 